Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
暂无分享,去创建一个
[1] Kenichi Watanabe,et al. A Novel 5-HT2 Antagonist, Sarpogrelate Hydrochloride, Shows Inhibitory Effects on Both Contraction and Relaxation Mediated by 5-HT Receptor Subtypes in Porcine Coronary Arteries , 2000, Pharmacology.
[2] M. Nakazawa,et al. Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-for myl-4-piperidinecarboxamide monohydrochloride monohydrate), on contraction and relaxation of pig coronary arteries induced by 5-HT and alpha-methylsero , 2000, Biological & pharmaceutical bulletin.
[3] H. Kihara,et al. AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats. , 2000, Journal of cardiovascular pharmacology.
[4] P. Zahradka,et al. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. , 1999, The Journal of pharmacology and experimental therapeutics.
[5] Y. Nakata,et al. Binding affinity of sarpogrelate to 5-HT(2A) receptor ligand recognition sites in rat renal cortical and mesangial cells in culture. , 1999, General pharmacology.
[6] K. Sasaki,et al. Bopindolol Is a Slowly Dissociating β1-Adrenoceptor Antagonist When Compared to Other β-Blockers , 1995 .
[7] R. Eglen,et al. The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors , 1995, British journal of pharmacology.
[8] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[9] N. Yagi,et al. Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet. , 1991, Journal of pharmacobio-dynamics.
[10] Y. Takada,et al. MCI-9042: high affinity for serotonergic receptors as assessed by radioligand binding assay. , 1991, Journal of pharmacobio-dynamics.
[11] J. De Keyser,et al. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes. , 1989, European journal of pharmacology.
[12] J. Aono,et al. Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin bindings to serotonergic (5HT1 and 5HT2) receptors in dog brain and aorta. , 1988, Chemical & pharmaceutical bulletin.
[13] J. Leysen,et al. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. , 1985, Molecular pharmacology.
[14] J. Leysen. Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites , 1984, Neuropharmacology.
[15] J. Leysen,et al. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin. , 1983, European journal of pharmacology.
[16] J. Leysen,et al. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.
[17] J. V. van Beek,et al. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. , 1981, The Journal of pharmacology and experimental therapeutics.
[18] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[19] M. Nakazawa,et al. A novel 5-HT(2) antagonist, sarpogrelate hydrochloride, shows inhibitory effects on both contraction and relaxation mediated by 5-HT receptor subtypes in porcine coronary arteries. , 2000, Pharmacology.
[20] K. Sasaki,et al. A non-selective β-blocker, bopindolol, exhibits high affinity to 5-HT1A receptor subtype in rat brain as assayed by competition binding experiments , 1996 .
[21] O. Brodde. 5-Hydroxytryptamine-receptor subtypes. , 1990, Clinical physiology and biochemistry.